NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.

Saved in:
Bibliographic Details
Title: NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.
Authors: Lee CH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin YC; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang YC; TMU Research Center of Cancer Translational Medicine and Taipei Cancer Center, Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chen PC; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin KH; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yeh TM; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Leung EY; Auckland Cancer Society Research Centre and Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand., Lin IL; Department of Radiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan., Chen SH; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Cheung CHA; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Source: Journal of Cancer [J Cancer] 2025 Feb 11; Vol. 16 (5), pp. 1694-1708. Date of Electronic Publication: 2025 Feb 11 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1837-9664
DOI:10.7150/jca.105425